Oral Antidiabetic Agents in Patients with Chronic Kidney Disease.
10.4093/jkd.2011.12.4.194
- Author:
You Cheol HWANG
1
Author Information
1. Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea. khmcilyong@naver.com
- Publication Type:Original Article
- Keywords:
Oral administration;
Hypoglycemic agents;
Chronic kidney failure
- MeSH:
Administration, Oral;
Diabetes Mellitus;
Glomerular Filtration Rate;
Humans;
Hypoglycemic Agents;
Kidney Failure, Chronic;
Renal Insufficiency, Chronic
- From:Journal of Korean Diabetes
2011;12(4):194-197
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Diabetes mellitus is the leading cause of chronic kidney disease worldwide. At present, a variety of classes of oral hypoglycemic agents are available to improve glycemic control, including newer classes of drugs such as DPP-IV inhibitors. Decreased renal function with reduced glomerular filtration rate affects the choices, dosing, and monitoring of oral hypoglycemic agents, as some agents require dose adjustments in patients with chronic kidney disease and others are entirely contraindicated. This article reviews the clinical use of oral hypoglycemic agents, focusing on pharmacokinetic properties and dosing in patients with chronic kidney disease.
